As per the latest Enforcement Report of the US Food and Drug
Administration (USFDA), the Mumbai-based company is recalling Cefdinir
for oral suspension USP, 250 mg/5mL, packaged in 60 ml bottles.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-recalls-35928-bottles-of-generic-antibiotic-drug-cefdinir-in-the-us-market/articleshow/77313074.cms
No comments:
Post a Comment